Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus

Diagnostic Microbiology and Infectious Disease

Volumn 43, Issue 3, 2002, Pages 225-232

  Almer, Laurel S ^a   Shortridge, Virginia D ^a   Nilius, Angela M ^a   Beyer, Jill M ^a   Soni, Niru B ^a   Bui, Mai H ^a   Stone, Gregory G ^b   Flamm, Robert K ^a  

^a ABBOTT LABORATORIES   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COMMUNITY; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC VARIABILITY; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RIBOTYPING; STAPHYLOCOCCUS INFECTION;

ADULT; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; DNA GYRASE; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0036063106     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00394-2     Document Type: Article

References (34)

1. Methicillin-resistant Staphylococcus aureus in two child care centers
2. Genetic aspects of methicillin resistance in Staphylococcus aureus and methods used for its detection in clinical laboratories in the United States
3. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus
4. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999
5. From the Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999
6. Clinical microscopy
7. GyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee
8. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus
9. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluoroquinolones
10. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory
11. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
12. Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria
13. Basic aspects of antibiotic resistance in the multiresistant staphylococcus: An overview
14. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital
15. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
16. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among Staphylococci
17. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program
18. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis
19. Identification of Methicillin-Resistant Staphylococcus aureus
20. Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group
21. DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates
22. Prevalence of resistance to MLS antibiotics in 20 European hospitals participating in the European SENTRY surveillance programme. SENTRY Participants Group
23. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community
24. Novel mechanism of macrolide resistance in Streptococcus pneumoniae
25. Bacterial resistance to tetracycline: Mechanisms, transfer, and clinical significance
26. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: Role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis
27. Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones
28. New mechanism for methicillin resistance in Staphylococcus aureus: Clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity
29. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus
30. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988
31. Antibiotic resistance in gram-positive bacteria: Epidemiological aspects
32. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus